Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01244100 · ClinicalTrials.gov registry record · Phase 1
Food-Effect Pharmacokinetic Study of PL2200
A Phase 1 study, sponsored by PLx Pharma.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT01244100 is a Phase 1 study that has completed, run by PLx Pharma. The registered enrollment target is 20 participants.
The verdict
NCT01244100, a Phase 1 study, has completed, sponsored by PLx Pharma.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
This trial is a food-effect study to assess fasted versus fed pharmacokinetics of PL2200.
Interventions
- DRUG PL2200 fasted
- DRUG PL2200 fed
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01244100
The ClinicalTrials.gov registry entry for NCT01244100 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is PLx Pharma, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which PL2200 fasted is the first listed.
NCT01244100 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01244100 about?
NCT01244100 is a clinical study titled "Food-Effect Pharmacokinetic Study of PL2200". This trial is a food-effect study to assess fasted versus fed pharmacokinetics of PL2200.
What is the current status of trial NCT01244100?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2010-10.
What interventions are being tested in trial NCT01244100?
The interventions under investigation include: PL2200 fasted (DRUG), PL2200 fed (DRUG).
Who is sponsoring clinical trial NCT01244100?
This trial is sponsored by PLx Pharma, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.